Skip to main content
. 2017 Sep 27;8(57):97153–97164. doi: 10.18632/oncotarget.21315

Figure 5. Bioluminescent imaging of anterior cruciate ligament transaction induced-osteoarthritis (ACLT-OA) mice injected with iBMSCs-mCL.

Figure 5

(A) In vivo bioluminescence of sham group (left panel), establishment of ACLT-OA for one month and then injected with PBS (middle panel) and iBMSCs-mCL (right panel) for another one month. These mice were then non-invasively detected using IVIS200 for tracing injected cells. (B) Quantification of imaging as mean of each group.